Correlation Between Emergent Biosolutions and Deciphera Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Emergent Biosolutions and Deciphera Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Emergent Biosolutions and Deciphera Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Emergent Biosolutions and Deciphera Pharmaceuticals LLC, you can compare the effects of market volatilities on Emergent Biosolutions and Deciphera Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Emergent Biosolutions with a short position of Deciphera Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Emergent Biosolutions and Deciphera Pharmaceuticals.
Diversification Opportunities for Emergent Biosolutions and Deciphera Pharmaceuticals
0.03 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Emergent and Deciphera is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding Emergent Biosolutions and Deciphera Pharmaceuticals LLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Deciphera Pharmaceuticals and Emergent Biosolutions is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Emergent Biosolutions are associated (or correlated) with Deciphera Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Deciphera Pharmaceuticals has no effect on the direction of Emergent Biosolutions i.e., Emergent Biosolutions and Deciphera Pharmaceuticals go up and down completely randomly.
Pair Corralation between Emergent Biosolutions and Deciphera Pharmaceuticals
Considering the 90-day investment horizon Emergent Biosolutions is expected to generate 2.53 times more return on investment than Deciphera Pharmaceuticals. However, Emergent Biosolutions is 2.53 times more volatile than Deciphera Pharmaceuticals LLC. It trades about 0.03 of its potential returns per unit of risk. Deciphera Pharmaceuticals LLC is currently generating about -0.01 per unit of risk. If you would invest 1,179 in Emergent Biosolutions on August 24, 2024 and sell it today you would lose (231.00) from holding Emergent Biosolutions or give up 19.59% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 32.06% |
| Values | Daily Returns |
Emergent Biosolutions vs. Deciphera Pharmaceuticals LLC
Performance |
| Timeline |
| Emergent Biosolutions |
| Deciphera Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Emergent Biosolutions and Deciphera Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Emergent Biosolutions and Deciphera Pharmaceuticals
The main advantage of trading using opposite Emergent Biosolutions and Deciphera Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Emergent Biosolutions position performs unexpectedly, Deciphera Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Deciphera Pharmaceuticals will offset losses from the drop in Deciphera Pharmaceuticals' long position.| Emergent Biosolutions vs. Zoetis Inc | Emergent Biosolutions vs. Bausch Health Companies | Emergent Biosolutions vs. Neurocrine Biosciences | Emergent Biosolutions vs. Akanda Corp |
| Deciphera Pharmaceuticals vs. ANI Pharmaceuticals | Deciphera Pharmaceuticals vs. Phibro Animal Health | Deciphera Pharmaceuticals vs. Prestige Brand Holdings | Deciphera Pharmaceuticals vs. Evotec SE ADR |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Complementary Tools
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |